Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: New Zealand Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20054
20071
20093
20111
20121
20132
20182
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation10
Abbott Medical Devices1
Amarin Pharma Inc.1
Bayer1
CSL Behring1
Eli Lilly and Company1
Sunnybrook Health Sciences Centre1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease17
Atherosclerosis3
Cardiovascular Diseases3
Heart Diseases3
Acute Coronary Syndrome2
Coronary Disease2
Kidney Diseases2
Myocardial Ischemia2
Peripheral Arterial Disease2
Vascular Diseases2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.